Breaking News

AAIPharma Expands Lab Services at Technology Center

January 22, 2013

Adds capabilities and instrumentation

AAIPharma Services Corp. has expanded its lab service offerings, capabilities and instrumentation at its Technology Center in Wilmington, NC. The Technology Center, which opened in May 2012, has added new ICP-MS, GC-MS, LC-MS, UPLC and HPLC systems to its instrumentation and capabilities. A Malvern Mastersizer 3000 particle size analyzer was added to support preformulation and material testing services.
The company also added a ProteinSimple MFI 5200 micro-flow imaging system, a Wyatt Dawn Heleos II multi-angle laser light scattering (MALS) detector and a Wyatt DynaPro NanoStar dynamic light scattering (DLS) detector to support biopharma development services, as well as a ProteinSimple iCE3 capillary IEF to further support protein analyses.
AAIPharma also expanded its extractable and leachable (E&L) testing services to evaluate and qualify the materials used in the manufacturing process and final product configuration. New capabilities include a Foss Soxtec 2050 automated extraction system to enable reproducible and robust methodologies.
"AAIPharma specializes in comprehensive service offerings and offers the latest in instrumentation for our clients," said Patrick Walsh, chief executive officer of AAIPharma. "Since its grand opening, the Technology Center has been recognized for its modern, efficient operations and has exceeded client expectations as a world class laboratory."

Related Contract Manufacturing:

blog comments powered by Disqus
  • Solid Dispersions

    Solid Dispersions

    Robert Harris, Juniper Pharma Services||April 5, 2016
    A universal formulation strategy for poorly soluble drugs?

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements